Obermatt

Inogen

NSQ:INGN · US45780L1044
Health Care Equipment & SuppliesSmall

360

39
Profit price76
Owner Earnings Yield1
Dividend Yield1
Price/Sales91
EV / Gross Profit100
Price/Book69
Return on Capital47
Cash Return on Capital57
Return on Equity61
EBIT Margin49
Gross Profitability71
Accruals28
Owner Earnings Margin59
Sales growth32
Profit growth73
Reinvestment8
Price momentum53
Debt load87
Refinancing71
Debt Payback1
Liquidity3
Analyst ratings67
Opinion Changes50
Price Target Upside84
Market mood20
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Inogen doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2001
Employees612
Websiteinogen.com
ISINUS45780L1044
Last UpdateApr 2, 2026
Themes
PulmonologyRespiratoryBiomedical EngineeringHealth CareManufacturingMedical Device

Description

Inogen, Inc. (Inogen) is a medical technology business that primarily focuses on respiratory health. The company develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver suppl…

Analysis

Middle-of-the-road

Inogen, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
47
2023202420252026

All-time high

77

Jan 2025

All-time low

16

Jan 2024

Average rank

38

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
91
80
93
83
Price/Earnings
96
96
96
32
Price/Book
69
80
96
91
Dividend Yield
1
1
1
1
Value (overall)
80
73
85
67

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Inogen with its peers
Tactile Systems Technology
NMQ:TCMD
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
KORU Medical Systems
NAQ:KRMD
40
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
TransMedics Group
NMQ:TMDX
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Sight Sciences
NSQ:SGHT
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
CVRx
NSQ:CVRX
30
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Alphatec
NSQ:ATEC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →